Ivosimab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ivosimab, covering 2025-05-15 to 2025-05-15. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Multicenter Study: Ivosimab + Chemotherapy as Neoadjuvant for Resectable pMMR/MSS CRC Liver Mets [Phase 2]